Long‐acting muscarinic antagonist + long‐acting beta agonist versus long‐acting beta agonist + inhaled corticosteroid for COPD: A systematic review and meta‐analysis

Publisher： John Wiley & Sons Inc

E-ISSN： 1440-1843|20|8|1153-1159

ISSN： 1323-7799

Source： RESPIROLOGY (ELECTRONIC), Vol.20, Iss.8, 2015-11, pp. : 1153-1159

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Risk of all-cause hospitalization in COPD patients initiating long-acting or short-acting beta agonist therapy

By Bollu Vamsi  

Journal of Medical Economics, Vol. 16, Iss. 8, 2013-08 ,pp. : 1082-1088

Informa Healthcare

Access to resources Recommend Favorite

Indacaterol, a novel inhaled, once-daily, long-acting beta 2 -agonist for the treatment of obstructive airways diseases

By Beeh Kai  

Advances in Therapy, Vol. 26, Iss. 7, 2009-07 ,pp. : 691-699

Springer Publishing Company

Access to resources Recommend Favorite

Addition of a 5-lipoxygenase-activating protein inhibitor to an inhaled corticosteroid (ICS) or an ICS/long-acting beta-2-agonist combination in subjects with asthma

By Snowise Neil G.   Clements Diane   Ho Shu-Yen   Follows Richard M.A.  

Current Medical Research and Opinion, Vol. 29, Iss. 12, 2013-12 ,pp. : 1663-1674

Informa Healthcare

Access to resources Recommend Favorite

Long-acting formulation of a new muscarinic receptor antagonist for the treatment of overactive bladder

By Teng Lesheng   Jiang Chaojun   Sun Fengying   Li Chunmei   Teng Lirong   Meng Qingfan   Lee Robert J.   Li Youxin  

Journal of Microencapsulation, Vol. 30, Iss. 2, 2013-03 ,pp. : 116-123

Informa Healthcare

Access to resources Recommend Favorite

The long‐acting β2‐adrenoceptor agonist olodaterol attenuates pulmonary inflammation

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 14, 2015-07 ,pp. : 3537-3547

John Wiley & Sons Inc

Access to resources Recommend Favorite